PharmaTrace received 300,000 HBAR funding through the Thrive Hedera program to support the development of what the company calls a regulated decentralized physical infrastructure network (DePIN) for the pharmaceutical supply chain.
Transition to an officially sanctioned model
PharmaTrace currently operates its tracking system on Hyperledger Fabric, providing serialization and compliance tools to pharmaceutical and healthcare clients. The company says the new funding will support its transition from a private permissioned ledger to a public permissioned architecture built on Hedera.
This transition is intended to enable broader interoperability while maintaining the privacy of sensitive business data. Public verification of supply chain events is expected to become a core feature of the upgraded network.
Hedera’s role in migration
Hedera’s hashgraph technology will be used to support several components of the planned system. PharmaTrace plans to utilize Hedera Token Service (HTS) to represent serialized products and Hedera Consensus Service (HCS) to record verifiable event logs originating from the existing fabric infrastructure.
Hedera’s mirror nodes allow regulators and authorized parties to independently verify specific supply chain events without accessing sensitive systems.
Position within the track and trace environment
PharmaTrace’s approach places it alongside other serialization and traceability providers such as TraceLink, Optel, MediLedger, and VeChain. The company says its hybrid model is designed to allow customers to introduce a public audit layer without having to redesign their internal compliance workflows.
Token Plan and Ecosystem Participation
PharmaTrace also outlined plans for a utility token intended for operational use within the network. This token is expected to be tied to reporting accuracy, platform access, and future governance features.
Additionally, the company plans to provide development resources, documentation and integration frameworks to the broader Hedera ecosystem, particularly in areas where regulated supply chains are involved.
